Editor's Memo
John Marcille
Jeff Kang, MD
In a system where people will soon shop for their benefits on exchanges, plans that offer the best customer service will have the edge
Medication Management
Thomas Reinke
Health plans are expanding MTM — once considered a Part D mainstay — to their commercial businesses.
Evidence Review
A summary of the ECRI Institute’s Emerging Technology Evidence Report
Legislation & Regulation
John Carroll
The need for health plans to cut administrative costs is hammering insurance brokers. Is this another instance of the law of unintended consequences?
Tomorrow’s Medicine
Thomas Morrow, MD
Brilinta’s price will be a significant factor in coverage decisions when Plavix goes off patent in May 2012
Plan Watch
Frank Diamond
If UnitedHealth Group’s effort to buy a large physician group proves successful, clinical execs will have even more oversight
News and Commentary
News and Commentary

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report